Clinical Impact and Feasibility of the Digital Implementation of a Structured Assessment in Patients ≥65 Years With Acute Leukemia: A Prospective Pilot Study
Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias
Trial Details
| Condition | Leukemia Acute Myeloid, Leukemia Acute Lymphoid Leukemia (ALL) |
| Intervention | Digital Structured Assessment Implementation |
| Phase | NA |
| Status | Active |
| Participants | 20 |
| Est. Completion | 1 May 2027 |
| Last Updated | 19 May 2026 |
Primary Outcome
Feasibility of Digital Implementation
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age ≥65 years. * Confirmed diagnosis of acute leukemia. * Active ambulatory follow-up in the Hematology Service. * Ability to complete questionnaires independently or with caregiver support. * Access to a compatible digital device (patient or caregiver). * Signed informed consent. Exclusion Criteria: * Severe cognitive impairment preventing participation (per clinical judgment and baseline screening). * Terminal clinical condition with limited life expectancy. * Non-resolvable technical impossibility of digital access.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service